NEWAMSTERDAM PHARMA COMPANY
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NEWAMSTERDAM PHARMA COMPANY *W EXP 99/99/999, CUSIP N62509117.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NEWAMSTERDAM PHARMA COMPANY *W EXP 99/99/999, CUSIP N62509117.